LAVAL, Quebec, Oct. 31, 2013 /PRNewswire via COMTEX/ -- Valeant Pharmaceuticals International, Inc. /quotes/zigman/122461/delayed/quotes/nls/vrx VRX -4.55% /quotes/zigman/122225/realtime CA:VRX -1.63% announces third quarter financial results for 2013.
-- Total Revenue $1.54 billion; an increase of 74% over the prior year
Help employers find you! Check out all the jobs and post your resume.
